// App-Quantinova.ai

P190/P190 : The role of neuronal CXCL13 chemokine expression in Multiple Sclerosis Pathology

Researchers

Presenter

  • R. E. James

Principal Investigators

  • A. C. Farquharson

  • H. C. Jacobs

  • I. C. Farkas

  • N. Mazarakis

  • R. Reynolds

Medical Centers

  • Medicine, Imperial College London, London, UNITED KINGDOM

  • Medicine, Imperial College London, London, UNITED KINGDOM

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Multiple Sclerosis

Biomarkers

  • C-X-C Motif Chemokine Ligand 13

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved